Cats are exceptional at hiding illness. This trait served their wild ancestors well — appearing weak in a predator-prey world is dangerous. In the clinical setting, it creates a real problem. Heart disease can progress quietly in a cat for months or years, and for some owners the first indication their cat has a cardiac condition is an emergency.
Feline cardiac disease behaves differently from canine cardiac disease — the diseases themselves are different, the presentations are different, and the treatment approaches differ considerably. Understanding the distinctions helps owners and their veterinarians stay ahead of this condition.
Hypertrophic Cardiomyopathy: The Dominant Feline Disease
Hypertrophic cardiomyopathy (HCM) is the most common heart disease in cats. Where dogs primarily develop valve problems or dilated (weakened) heart muscle, cats predominantly develop the opposite problem: the muscle thickens. The left ventricular wall and/or the interventricular septum hypertrophies, and the internal dimensions of the left ventricle decrease.
The consequences are mechanical and physiological. The stiffened, thickened muscle can't relax normally to fill with blood (diastolic dysfunction). The reduced chamber volume means less blood per beat. Filling pressures rise, and that pressure backs up into the left atrium and eventually into the pulmonary veins — leading to pulmonary edema or pleural effusion (fluid around the lungs).
For a comprehensive look at the genetics and mechanisms, see our article on hypertrophic cardiomyopathy in cats.
Genetic Predisposition
Maine Coon cats carry a mutation in the MYBPC3 gene (cardiac myosin binding protein C) that is strongly associated with HCM. Ragdoll cats have their own distinct MYBPC3 mutation. In these breeds, genetic testing is available and used in responsible breeding programs. However, negative genetic testing does not guarantee a cat will not develop HCM — other genetic factors and non-genetic causes exist, as established by veterinary genetic research.
Domestic shorthairs develop HCM at substantial rates despite no specific breed predisposition. Middle-aged to older male cats appear overrepresented in clinical case series, though females are also affected.
The Invisible Progression
Many cats with HCM are in what clinicians call the "occult" or preclinical phase — structural changes are present on echocardiography, but the cat shows no symptoms whatsoever. The cat eats well, plays normally, appears completely healthy. This phase can last years.
Progression to symptomatic disease is unpredictable. Some cats move from preclinical to congestive heart failure over many years; others decompensate rapidly. There is no reliable way to predict individual progression rate, which is why screening and regular monitoring matter.
The Screening Problem: No Murmur Doesn't Mean No Disease
In dogs, heart murmurs reliably accompany the most common cardiac diseases. In cats, HCM frequently produces no murmur. Alternatively, a murmur can be heard but caused by dynamic outflow obstruction (which may come and go with heart rate changes) rather than structural disease per se. And conversely, a gallop rhythm — an extra heart sound heard during auscultation — can indicate serious diastolic dysfunction without a murmur being present.
This is why cardiac auscultation alone has limited screening value in cats. Echocardiography is the only reliable way to assess the feline heart for HCM. Cardiac biomarkers, particularly NT-proBNP, have utility as a screening tool — an elevated level raises the pre-test probability enough to warrant echocardiographic evaluation.
Genetic testing for Maine Coon and Ragdoll mutations helps breeders but is not diagnostic for individual cats and doesn't detect non-mutation-associated HCM.
For detail on how heart murmurs in cats differ from the diagnostic value they carry in dogs, that article covers the nuances.
Other Feline Cardiomyopathies
HCM accounts for the majority of feline heart disease, but it's not the only form:
Restrictive cardiomyopathy (RCM): Scar tissue and fibrosis develop in the heart muscle or inner lining, restricting normal filling. The heart muscle thickness may be normal, but filling is severely impaired. Carries a particularly poor prognosis. The cat's atria often become dramatically enlarged, which significantly increases clot risk.
Dilated cardiomyopathy (DCM): The heart muscle weakens and dilates, the opposite of HCM. DCM was common in cats before taurine deficiency was identified as a key cause. With taurine now routinely supplemented in commercial cat food, true primary DCM is rare. When it occurs, possible causes include taurine deficiency, other nutritional deficiencies, or idiopathic causes.
Unclassified cardiomyopathy: Some cats have features of multiple cardiomyopathy types or features that don't fit neatly into established categories.
Signs of Heart Disease in Cats
The subtlety is the problem. Early disease: none. Cats in early-to-moderate disease may show reduced activity levels that owners attribute to aging. The signs that typically prompt veterinary attention:
- Open-mouth breathing — always abnormal in cats and frequently indicates respiratory distress from fluid accumulation
- Labored or rapid breathing — increased respiratory effort, nostril flaring, visible abdominal movement with breathing
- Sudden weakness or collapse of the hindlimbs — the saddle thrombus presentation (see below)
- Reduced appetite and weight loss
- Hiding and withdrawal — many cats with respiratory distress instinctively hide
A resting respiratory rate above 30-36 breaths per minute at home is a practical monitoring tool for cats diagnosed with cardiac disease.
The Saddle Thrombus Emergency
Aortic thromboembolism (ATE), colloquially called saddle thrombus, is the most feared complication of feline heart disease. A blood clot forms in the enlarged left atrium, travels through the aorta, and lodges at the aortic trifurcation (where the aorta splits into the vessels supplying the rear legs).
The result is acute, often dramatic: sudden bilateral rear limb paralysis or paresis, cold limbs, absent pulses in the femoral arteries, vocalization from pain, and bluish-grey foot pads (cyanosis). This is an acute emergency requiring immediate veterinary care.
Prognosis for ATE is variable and guarded. Some cats recover function over days to weeks; others do not. Recurrence is common. Long-term anticoagulant therapy (antiplatelet agents and/or anticoagulants) is used to reduce recurrence risk in cats with known cardiac disease, though studies show recurrence rates remain significant even with treatment.
Cardiac Disease Secondary to Other Conditions
Not all feline cardiac changes represent primary heart disease. Secondary cardiomyopathy — heart changes driven by another condition — is important to distinguish because treating the primary condition may improve cardiac function.
Hyperthyroidism is the classic example. An overactive thyroid in cats drives the heart to work faster and harder, often producing increased heart muscle mass that looks like HCM on echo. When hyperthyroidism is treated, the cardiac changes often improve or resolve. Every hyperthyroid cat should have blood pressure measured and cardiac assessment performed.
Hypertension from kidney disease or hyperthyroidism also stresses the heart and must be addressed as part of any cardiac management plan.
Treatment
Cats with preclinical HCM but no symptoms or evidence of enlargement: monitoring. There is currently no universally proven intervention that definitively slows progression in asymptomatic cats, though research into medications like atenolol and clopidogrel continues. The only intervention clearly shown to extend survival is treating congestive heart failure once it develops.
Cats with congestive heart failure (pulmonary edema or pleural effusion): diuretics to remove fluid, with reassessment of cardiac function once stabilized. Pleural effusion may require drainage (thoracocentesis) for immediate relief.
Anti-arrhythmic medications, rate control agents (like atenolol in cats with dynamic outflow obstruction), and antithrombotic therapy are individualized based on the cat's specific situation and complication risks.
The broader picture of heart health in dogs and cats provides context for how these treatment approaches fit into overall cardiac care.
When to see your vet: Any cat breathing with effort, breathing with its mouth open, showing sudden weakness or paralysis of the rear legs, or hiding without apparent cause should be seen immediately. For cats with known HCM, scheduled rechecks and home respiratory rate monitoring are the pillars of early decompensation detection.
FAQ
Can cats live a long life with HCM?
Many do. Cats in the preclinical phase can live years with no symptoms and excellent quality of life. Progression varies enormously. Regular monitoring allows early intervention when the disease does advance.
Is HCM painful for cats?
The disease itself is not typically painful. Respiratory distress from fluid accumulation is uncomfortable and frightening. Saddle thrombus is acutely and severely painful. This is part of why early detection and monitoring matter.
Should I get my Maine Coon or Ragdoll tested genetically for HCM?
Genetic testing identifies cats carrying known mutations, which is valuable for breeders making pairing decisions. For individual pets, a positive result means the cat should have regular echocardiographic screening. A negative result doesn't mean the cat is free from risk — other genetic variants and non-genetic HCM exist. Echo screening is more definitive.
Does diet affect HCM risk in cats?
For primary HCM, diet has not been established as a causative or protective factor. The diet-DCM connection seen in dogs involves a different disease and doesn't apply to feline HCM. Ensuring adequate taurine intake (met by any commercial cat food formulated to AAFCO standards) remains important for preventing DCM specifically.